Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset

Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset

Background: It has been recommended that any invasive treatment performed in patients with central serous chorioretinopathy (CSCR) not be initiated earlier than four months after disease onset due to the potential for spontaneous remission of symptoms. The goal of this study was to examine the outco...

Full description

Bibliographic Details
Main Authors: Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Małgorzata Kneba, Andrzej Grzybowski
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Journal of Clinical Medicine
Subjects:
central serous chorioretinopathy
subthreshold micropulse laser
subretinal fluid
photodynamic therapy
Online Access:https://www.mdpi.com/2077-0383/8/9/1398

Similar Items

Similar Items